Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in Luxembourg

HIV Clinical Trials

Volumn 3, Issue 3, 2002, Pages 195-201

  Roman, François ^a   Franck, Nathalie ^a   Burgy, Catherine ^a   Servais, Jean ^a   Zimmer, Jean Marie ^a   Mossong, Joël ^a   Goubau, Patrick ^a   Schneider, François ^a   Hemmer, Robert ^a   Schmit, Jean Claude ^a  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

Allele frequency; HIV co receptors; Polymorphisms

Indexed keywords

CHEMOKINE RECEPTOR CCR5; VIRUS RECEPTOR;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUXEMBOURG; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VOLUNTEER;

EID: 0036302739     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/5EY7-2KVG-FE6L-6VWH     Document Type: Article

References (24)

1. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
2. Identification of a major co-receptor for primary isolates of HIV-1
3. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
4. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
5. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
6. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
7. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
8. Effects of CCR5-delta32, CCR2-641, and SDF-1 3′A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data
9. The genetics of HIV coreceptors and coreceptor ligands
10. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
11. Analysis of the CC chemokine receptor 5 m303 mutation in infants born to HIV-1-seropositive mothers
12. CCR5 promoter polymorphism and HIV-1 disease progression
13. Genetic acceleration of AIDS progression by a promoter variant of CCR5
14. Global distribution of the CCR2-641/CCR5-59653T HIV-1 disease-protective haplotype
15. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
16. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
17. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
18. 3CR1
19. 3CR1 and risk of HIV disease
20. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
21. Maternal SDF1 3′A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission
22. Performing the exact test of Hardy-Weinberg proportion for multiple alleles
23. 3CR1 genotype with implications for HIV disease progression
24. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy